Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Papillary renal cell carcinoma, sporadic
0.300 Biomarker disease CLINGEN c-Met inhibitors with novel binding mode show activity against several hereditary papillary renal cell carcinoma-related mutations. 18055465 2008
Papillary renal cell carcinoma, sporadic
0.300 Biomarker disease CLINGEN The MET oncogene drives a genetic programme linking cancer to haemostasis. 15772665 2005
Papillary renal cell carcinoma, sporadic
0.300 Biomarker disease CLINGEN Activating Met mutations produce unique tumor profiles in mice with selective duplication of the mutant allele. 15557554 2004
Papillary renal cell carcinoma, sporadic
0.300 Biomarker disease CLINGEN Hereditary and sporadic papillary renal carcinomas with c-met mutations share a distinct morphological phenotype. 10433944 1999
Papillary renal cell carcinoma, sporadic
0.300 Biomarker disease CLINGEN Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. 9140397 1997
Papillary renal cell carcinoma, sporadic
0.300 Biomarker disease CLINGEN Activating mutations for the met tyrosine kinase receptor in human cancer. 9326629 1997
Papillary renal cell carcinoma, sporadic
0.300 Biomarker disease CLINGEN The receptor encoded by the human c-MET oncogene is expressed in hepatocytes, epithelial cells and solid tumors. 1917129 1991